bendamustine hydrochloride has been researched along with Anemia, Hemolytic, Autoimmune in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Berentsen, S; Tjønnfjord, GE | 1 |
| Barcellini, W; Berentsen, S; Broome, CM; Gertz, MA; Hill, A; Hill, QA; Jäger, U; Jilma, B; Kuter, DJ; Michel, M; Montillo, M; Röth, A; Zeerleder, SS | 1 |
| Barcellini, W; Berentsen, S; Brudevold, R; D'Sa, S; Dahm, AEA; Dalgaard, J; Fattizzo, B; Frøen, H; Hallstensen, RF; Haukås, E; Hjorth-Hansen, H; Jæger, PH; Kell, M; Małecka, A; Oksman, M; Randen, U; Rolke, J; Sekhar, M; Sørbø, JH; Tjønnfjord, E; Tjønnfjord, GE; Tsykunova, G; Tvedt, THA | 1 |
| Berentsen, S | 4 |
| Eren, R; Suyanı, E | 1 |
| De Guibert, S; Delmer, A; Dupuis, J; Feugier, P; Guieze, R; Levy, V; Michallet, AS; Quinquenel, A; Royer, B; Willekens, C; Ysebaert, L | 1 |
| Aimoto, M; Hirai, M; Inoue, A; Kameda, K; Kanashima, H; Kuno, M; Nakao, T; Yamane, T; Yoshida, M | 1 |
| Autore, F; Bellesi, S; Chiusolo, P; Coscia, M; D'Arena, G; Efremov, DG; Innocenti, I; Laurenti, L; Mauro, FR; Mondello, P; Sica, S | 1 |
| De Crescenzo, A; Gottardi, D; Gueli, A; Hu, H; Ricca, I; Tarella, C | 1 |
| Böhme, A; Hoelzer, D; Koschmieder, S; Seipelt, G | 1 |
6 review(s) available for bendamustine hydrochloride and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?
Topics: Anemia, Hemolytic, Autoimmune; B-Lymphocytes; Bendamustine Hydrochloride; Humans; Prospective Studies; Rituximab | 2022 |
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.
Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic, Autoimmune; Bendamustine Hydrochloride; Coombs Test; Disease Management; Humans; Rituximab | 2020 |
How I treat cold agglutinin disease.
Topics: Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bendamustine Hydrochloride; Complement Inactivating Agents; Disease Management; Female; Humans; Middle Aged; Rituximab; Thrombosis | 2021 |
How I manage patients with cold agglutinin disease.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Bendamustine Hydrochloride; Bortezomib; Humans; Rituximab | 2018 |
[Alleviated anemia by bendamustine in cold agglutinin disease associated with small lymphocytic lymphoma].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Nitrogen Mustard Compounds; Rituximab; Treatment Outcome | 2015 |
Cold agglutinin disease.
Topics: Anemia, Hemolytic, Autoimmune; B-Lymphocytes; Bendamustine Hydrochloride; Complement C3b; Humans; Lymphoproliferative Disorders; Rituximab | 2016 |
1 trial(s) available for bendamustine hydrochloride and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Cold agglutinin disease revisited: a multinational, observational study of 232 patients.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Rituximab; Vidarabine | 2020 |
6 other study(ies) available for bendamustine hydrochloride and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Bendamustine Hydrochloride; Coombs Test; False Positive Reactions; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Rituximab | 2018 |
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
Topics: Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Retrospective Studies; Rituximab; Survival Analysis | 2015 |
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Humans; Incidence; Italy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Rituximab | 2016 |
Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Blood Transfusion; Humans; Immunologic Factors; Male; Nitrogen Mustard Compounds; Rituximab | 2013 |
Therapy for chronic cold agglutinin disease: perspective for further improvements.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Bendamustine Hydrochloride; Chronic Disease; Humans; Nitrogen Mustard Compounds; Rituximab | 2013 |
Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Marrow; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Nitrogen Mustard Compounds; Remission Induction; Rituximab; Treatment Failure | 2001 |